Akoya Biosciences (AKYA) said late Thursday it appointed Scott Mendel as board chairman, effective the day before, succeeding Robert Shepler.
Mendel has been an Akoya board member since 2021. He previously served as chief executive of GenMark Diagnostics.
Shepler remains a member of Akoya's board, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.